4DMedical's (ASX:4DX) CT:VQ imaging technology received CE Mark certification for commercial use across the European Union, according to a Friday filing with the Australian bourse.

The company also received firm commitments to raise AU$83 million through the placement of about 14.1 million shares at AU$5.90 apiece, the filing said.

Proceeds will be used to fund the commercial launch of CT:VQ in Europe and international markets, support clinical integration for new customers, and strengthen the balance sheet, per the filing.

Shares rose nearly 10% in morning trade Friday and earlier reached an all-time high.